Huntsman Corporation
NYSE:HUNChemicals
-$0.46 today
- Market cap
- $1.58B
- Beta
- 0.66
- P/E (TTM)
- -6.6
- EPS (TTM)
- -$1.87
- Dividend yield
- 4.18%
Volume 3.62M
Average 5.21M
HUN Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Huntsman CorporationNYSE: HUN
Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026
Cost of revenue growth accelerates
Q1 FY2026 cost of revenue of $1.24B rose 2.3% year over year, ahead of the -2.9% change in trailing-twelve-month cost of revenue. Sequentially, it rose 3.9% from the prior quarter. Over 3 fiscal years it compounded at -8.7% a year.
Context
- Cost of revenue amounted to 86.8% of revenue in FY2025, up 1.1 pp from a year earlier.
- Cost of revenue increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +2.3% holds above the trailing-twelve-month pace of -2.9%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 4.93B USD
- Year-over-year change
- -4.6%
- 4-year CAGR
- -5.1%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 4.93B | -4.6% |
| FY2024 | 2024-12-31 | 5.17B | -0.7% |
| FY2023 | 2023-12-31 | 5.21B | -19.6% |
| FY2022 | 2022-12-31 | 6.48B | +6.4% |
| FY2021 | 2021-12-31 | 6.09B | — |
Cost of Revenue vs competitors
How HUN compares with its peers on the latest reported figures
- Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -2.9% is the 8th highest of 10, against a peer median of +7.5%.
- Cost of revenue amounts to 87.1% of revenue for HUN, versus a peer median of 82.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | R$65.4B BRL | -10.2% | -7.3% | 98.0% | |
| LTM Mar 2026 | $4.96B USD | -2.9% | -8.7% | 87.1% | |
| LTM Jun 2026 | $4.91B USD | +2.1% | -2.0% | 84.7% | |
| LTM Jun 2026 | $3.66B USD | +31.4% | -1.4% | 88.5% | |
| LTM Mar 2026 | CA$528.16M CAD | +7.5% | +13.8% | 68.7% | |
| LTM Mar 2026 | $185.73M USD | +5.9% | +10.3% | 42.5% | |
| LTM Mar 2026 | $22.18M USD | +704.4% | — | 82.4% | |
| FY2025 | $2.27M USD | +250.9% | +145.9% | — | |
| LTM Jan 2026 | CA$155.21K CAD | -51.9% | +59.0% | — | |
| LTM Mar 2026 | $10K USD | +134.5% | — | — | |
| LTM Jun 2025 | $0 USD | — | — | 0.0% | |
| Peer median (excluding HUN) | — | +7.5% | +10.3% | 82.4% | |
Competitors are the stored peer set for HUN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 7.67B | 8.02B | 6.11B | 6.04B | 5.68B |
| Cost of Revenue | 6.09B | 6.48B | 5.21B | 5.17B | 4.93B |
| Gross Profit | 1.58B | 1.55B | 906M | 866M | 751M |
| Gross Margin | 20.7% | 19.3% | 14.8% | 14.3% | 13.2% |
| Research & Development | 135M | 125M | 115M | 121M | 120M |
| Selling, General & Admin | 739M | 711M | 689M | 671M | 670M |
| Operating Expenses | 853M | 874M | 822M | 891M | 790M |
| Depreciation & Amortization | 278M | 281M | 278M | 289M | 287M |
| EBITDA | 1.59B | 1.04B | 442M | 329M | 174M |
| EBITDA Margin | 20.7% | 13.0% | 7.2% | 5.5% | 3.1% |
| Operating Income | 731M | 672M | 84M | (25M) | (39M) |
| Operating Margin | 9.5% | 8.4% | 1.4% | -0.4% | -0.7% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 67M | 62M | 65M | 79M | 79M |
| Other Income / Expenses | 515M | 25M | 15M | (14M) | (153M) |
| Income Before Tax | 1.25B | 697M | 99M | (39M) | (192M) |
| Pre-Tax Margin | 16.2% | 8.7% | 1.6% | -0.6% | -3.4% |
| Income Tax Expense | 191M | 186M | 64M | 61M | 26M |
| Net Income | 1.05B | 460M | 101M | (189M) | (275M) |
| Net Margin | 13.6% | 5.7% | 1.7% | -3.1% | -4.8% |
| EPS (Basic) | 4.77 | 2.29 | 0.57 | (1.10) | (1.59) |
| EPS (Diluted) | 4.72 | 2.27 | 0.57 | (1.10) | (1.59) |
| Weighted Avg Shares | 219.2M | 201M | 177.4M | 172.1M | 172.6M |
| Weighted Avg Shares (Diluted) | 221.4M | 203M | 177.4M | 172.1M | 172.6M |
Huntsman Corporation
NYSE:HUN
Intrinsic Alpha fair value
Locked
Current Price
$9.03
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.